Some patients with treatment-resistant colorectal cancers may have a new option
The MET gene is known to be amplified in about 10 percent of colorectal cancers, and is associated with worse prognosis. The paper was also presented as part of an oral session at the 2013 American Society of Clinical Oncology Annual Meeting…